Loading clinical trials...
Loading clinical trials...
A Phase 3, Randomized, Double-blind, Placebo-controlled, Multi-center Trial to Evaluate the Safety and Efficacy of TX-004HR in Postmenopausal Women With Moderate to Severe Symptoms of Vulvar and Vaginal Atrophy
Conditions
Interventions
Estradiol
Placebo
Locations
105
United States
Medical Affiliated Research Center
Huntsville, Alabama, United States
Montogomery Women's Health
Montgomery, Alabama, United States
Cactus Clinical Research
Mesa, Arizona, United States
Arizona Wellness Center for Women
Phoenix, Arizona, United States
Radiant Research
Scottsdale, Arizona, United States
Visions Clinical Research - Tucson
Tucson, Arizona, United States
Start Date
September 1, 2014
Primary Completion Date
October 1, 2015
Completion Date
October 1, 2015
Last Updated
May 25, 2017
NCT07118891
NCT06798571
NCT07218445
NCT07472881
NCT06900374
NCT07257029
Lead Sponsor
TherapeuticsMD
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions